GlassScriptPhysician profile
Pamela S Schultz
NPI 1720335037
$533.92
in general payments reported to CMS, 2019-2025
17 companies · $97.23 in 2025
The $97.23 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $112 · 2022: $28.24 · 2023: $52.02 · 2024: $34.64 · 2025: $97.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $183.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $97.23 | 2025 | |
| Roche Diagnostics Corporation | $70.06 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.06 | 2019-2020 | |
| Abbvie INC. | $52.00 | 2019-2022 | |
| Allergan, INC. | $42.07 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $29.94 | 2023 | Myfembree |
| Exact Sciences Corporation | $22.08 | 2023 | Cologuard Collection Kit |
| Boston Scientific Corporation | $19.66 | 2019 | |
| Mayne Pharma Commercial LLC | $19.17 | 2024 | |
| Davol INC. | $18.35 | 2020 | |
| Daiichi Sankyo INC. | $15.47 | 2024 | Injectafer |
| Celularity INC. | $15.23 | 2020 | |
| Exeltis, USA INC. | $14.54 | 2019 | |
| Millicent US INC | $14.24 | 2019 | |
| Vertical Pharmaceuticals, LLC | $13.62 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $12.63 | 2020 | |
| Coopersurgical, INC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.